Ubs Group Ag Soligenix, Inc. Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
SELL
$0.4 - $168.0 $4,044 - $1.7 Million
-10,110 Reduced 68.98%
4,547 $2,000
Q3 2022

Nov 10, 2022
BUY
$0.51 - $117.79 $7,475 - $1.73 Million
14,657 New
14,657 $6,000
Q2 2022

Aug 10, 2022
SELL
$0.4 - $0.75 $2,590 - $4,856
-6,475 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$0.61 - $0.75 $9,620 - $11,828
-15,771 Reduced 70.89%
6,475 $5,000
Q4 2021

Feb 14, 2022
BUY
$0.66 - $1.1 $9,337 - $15,562
14,148 Added 174.71%
22,246 $15,000
Q3 2021

Nov 15, 2021
BUY
$0.9 - $1.31 $7,288 - $10,608
8,098 New
8,098 $9,000
Q2 2021

Aug 13, 2021
SELL
$0.87 - $1.58 $1,729 - $3,141
-1,988 Closed
0 $0
Q1 2021

May 12, 2021
BUY
$1.31 - $2.35 $2,500 - $4,486
1,909 Added 2416.46%
1,988 $3,000
Q3 2020

Nov 12, 2020
SELL
$1.7 - $2.61 $5,621 - $8,631
-3,307 Reduced 97.67%
79 $0
Q2 2020

Jul 31, 2020
BUY
$1.36 - $2.26 $4,497 - $7,473
3,307 Added 4186.08%
3,386 $7,000
Q1 2020

May 01, 2020
SELL
$1.42 - $3.34 $1,411 - $3,319
-994 Reduced 92.64%
79 $0
Q4 2019

Feb 14, 2020
SELL
$0.87 - $1.45 $4,840 - $8,067
-5,564 Reduced 83.83%
1,073 $1,000
Q3 2019

Nov 14, 2019
SELL
$0.72 - $1.31 $871 - $1,586
-1,211 Reduced 15.43%
6,637 $6,000
Q2 2019

Aug 14, 2019
SELL
$0.67 - $0.91 $3,147 - $4,275
-4,698 Reduced 37.45%
7,848 $6,000
Q1 2019

May 14, 2019
BUY
$0.88 - $1.04 $2,106 - $2,489
2,394 Added 23.58%
12,546 $11,000
Q4 2018

Feb 14, 2019
BUY
$0.85 - $2.1 $8,519 - $21,048
10,023 Added 7769.77%
10,152 $9,000
Q2 2018

Aug 14, 2018
SELL
$0.92 - $1.91 $2,123 - $4,408
-2,308 Reduced 94.71%
129 $0
Q1 2018

May 15, 2018
BUY
$1.92 - $2.4 $4,527 - $5,659
2,358 Added 2984.81%
2,437 $5,000
Q4 2017

Feb 14, 2018
SELL
$1.84 - $2.32 $3,847 - $4,851
-2,091 Reduced 96.36%
79 $0
Q3 2017

Nov 14, 2017
SELL
$2.01 - $2.27 $576 - $651
-287 Reduced 11.68%
2,170 $5,000
Q2 2017

Aug 14, 2017
SELL
N/A
-3,764 Reduced 60.5%
2,457 $5,000
Q1 2017

Nov 14, 2017
BUY
N/A
6,221
6,221 $17,000

Others Institutions Holding SNGX

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About SOLIGENIX, INC.

SNGX Quotes by TradingView
  • Ticker SNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,105,200
  • Market Cap $162M
  • Description
  • Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...
More about SNGX
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email